PT-141
MODERATE EVIDENCEAlso known as: Bremelanotide
Analogue of an approved drug substance — research supply is NOT an approved medicine
Educational Overview
A melanocortin receptor agonist. The reference molecule completed clinical trials and is the active ingredient of an FDA-approved prescription product for a specific indication.
Research Mechanism
Acts on central melanocortin receptors rather than the vascular pathways targeted by other compounds studied in the same area.
Areas of Study
- Melanocortin signalling (clinical)
Safety Considerations
Research-supplied material is not an approved medicine and is not interchangeable with prescription products. Not for human use. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.